Search Ontology:
ChEBI

lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Term ID
CHEBI:72749
Synonyms
  • (2R)-1-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-3-hydroxypropan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
  • LPE 0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
  • LPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • Lyso-PE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • PE 0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
  • PE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Definition
A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Phenotype where environments contain lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Phenotype modified by environments containing lysophosphatidylethanolamine (0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Human Disease / Model Data